AdAlta: A big development for fibrosis sufferers … and it could be lucrative too
Listen to ASX-listed AdAlta Managing Director Tim Oldham talk to Matt Birney on the Bulls N’ Bears Report about AdAlta’s extraordinary new drug that just might be a game changer for fibrosis sufferers.